Fed’s Barr Says Policy Adjustment Needed to Reach 2% Inflation Target
Fed Governor Michael Barr said inflation is not trending to 2% in a timely way and that further policy adjustments may be needed.
Fed Governor Michael Barr said inflation is not trending to 2% in a timely way and that further policy adjustments may be needed.
TC Energy said Coastal GasLink Phase 2 will proceed after LNG Canada approved its expansion, nearly doubling pipeline capacity with construction expected in 2027.
MMA.INC said annualized cash operating cost reductions exceeded $2.51 million after more than $800,000 of additional cuts since July.
Immix Biopharma reported an 89% complete response rate in its 45-patient NEXICART-2 trial and plans a final readout and BLA submission in mid-2027.
BeyondSpring launched an ATM offering of up to $11.9 million while transferring its China subsidiary interest and securing support for DUBLIN-4.
Aldeyra plans to seek FDA formal dispute resolution over reproxalap after three complete response letters and expects an FDA meeting in Q4 2026.
Pharming CEO Fabrice Chouraqui has stepped down immediately, with its CFO and chief commercial officer appointed interim co-CEOs.
AstraZeneca will invest $2 billion in Summit Therapeutics for a roughly 12% stake while collaborating on cancer drug trials.
Bitmine reported more than 6 million ETH and $17.2 billion in crypto, cash, securities and other holdings as of Sept. 27.
Fairfax Financial will buy back up to 2.03 million subordinate voting shares and 950,000 Series K preferred shares through September 2027.